Rasio cepet: InspireMD, Inc. (NSPR)

The current market value of InspireMD, Inc. (NSPR) shown on this chart is based on the success of CGuard systems, which are valued by vascular surgeons for reliable stroke prevention. However, product adoption rates and insurance reimbursements remain problematic areas amid competition with industry behemoths. Meanwhile, the company is optimizing costs by outsourcing component manufacturing to external partners through strict quality regulations, which constitutes 3.61.

For the high-tech cardiovascular stent manufacturer InspireMD, Inc. (NSPR), quick liquidity dynamics serve as an indicator of the company's ability to instantaneously settle obligations without liquidating inventory. This metric aggregates cash and accounts receivable and divides them by short-term debt, allowing investors to identify hidden cash gaps and assess the business's real solvency during inter-reporting periods.